IL-1Hy2
Alternative Names: IL1Hy2; Interleukin-1 receptor antagonist protein IL1Hy2Latest Information Update: 02 Jul 2004
At a glance
- Originator Nuvelo
- Class
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 02 Jul 2004 Discontinued - Preclinical for Rheumatoid arthritis in USA (unspecified route)
- 17 Feb 2000 Preclinical development for Rheumatoid arthritis in USA (Unknown route)